Venous Thromboembolism in Aggressive B-Cell Lymphoma Patients Treated with CD19 CAR-T Therapy: Single-Institution Study [0.03%]
CD19 CAR-T治疗的侵袭性B细胞淋巴瘤患者的静脉血栓栓塞：单中心研究
Neha Venkatesh,Kevin Milligan,Julia Parrish et al.
Neha Venkatesh et al.
Background: Large B-cell lymphomas (LBCLs) are a common subtype of non-Hodgkin lymphomas. CD19 chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized LBCL treatment, with high remission rates but also signifi...
A Pilot Project to Evaluate the Benefit of Additional Support in Haematopoietic Cell Transplant (HCT) Research Data Management on Behalf of Anthony Nolan and BSBMTCT [0.03%]
一项评估在造血细胞移植(HCT)研究数据管理中增加支持益处的试点项目 代表Anthony Nolan和BSBMTCT开展的研究
Shelley Hewerdine,Greg Judge,Julia Lee et al.
Shelley Hewerdine et al.
Background: The participation of transplant centres in research studies that request detailed follow-up data on included patients can be challenging due to the amount of time centre Data Managers have to complete addition...
Composite Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Diagnostic and Therapeutic Challenge [0.03%]
复合滤泡性淋巴瘤和慢性淋巴细胞白血病/小淋巴细胞淋巴瘤：诊断和治疗的挑战
Matthew T Ye,Yaling Yang,M James You
Matthew T Ye
Combined Antithrombin and Heparin Supplementation to Blood for Restoring Heparin Responsiveness After Andexanet Alfa Exposure: An In Vitro Model [0.03%]
体外模型联合抗凝血酶和肝素补充以恢复Andexanet Alpha暴露后的肝素反应性
Amir L Butt,Hisako Okada,Kofi B Vandyck et al.
Amir L Butt et al.
Background: Andexanet alfa, a Gla-domainless mutant factor Xa (GDXa), reverses oral FXa inhibitors but can cause severe heparin resistance during cardiopulmonary bypass (CPB). Antithrombin (AT) supplementation may mitigat...
Systemic Immune Alterations in Paediatric Classical Hodgkin Lymphoma With CCL17 and MCP-4 as Diagnostic and Predictive Biomarkers [0.03%]
儿童经典型霍奇金淋巴瘤的系统性免疫改变以及CCL17和MCP-4作为诊断和预测生物标志物的价值
Gustav Hedberg,Qi Chen,Tadepally Lakshmikanth et al.
Gustav Hedberg et al.
Background: Paediatric classical Hodgkin lymphoma (cHL) is the most common malignancy in adolescents, and despite excellent survival, a subset of patients experiences treatment failure or severe long-term toxicity, unders...
Rosuvastatin in Combination With Bortezomib Promotes Osteogenesis in Myeloma Bone Disease by Inhibiting the Secretion of CCL3 [0.03%]
rosuvastatin联合硼替佐米通过抑制CCL3分泌促进骨髓瘤骨病成骨作用
Fujun Qu,Mingxu Hui,Fan Yang et al.
Fujun Qu et al.
Background: Myeloma bone disease (MBD) is a devastating complication of multiple myeloma (MM) and a primary cause of disability in affected patients. Its pathogenesis is driven by an imbalance in bone remodeling, largely ...
Acute Myeloid Leukemia With Plasmacytoid Differentiating Cutaneous Lesions: A Case of Double Identity or Active Transformation [0.03%]
粒系伴浆细胞样分化急性髓系白血病的皮损一例：巧合抑或白血病活跃期的表现？
Benjamin J Lee,Shawn P Griffin,Deepa Jeyakumar et al.
Benjamin J Lee et al.
Introduction: Acute myeloid leukemia (AML) with plasmacytoid dendritic cell differentiation (pDC-AML) is a newly described subtype of leukemia with features resembling blastic plasmacytoid dendritic cell neoplasm (BPDCN)....
Ocular Involvement of Relapsed Nodal T Follicular Helper Cell Lymphoma, Angioimmunoblastic Type [0.03%]
复发性结节外T滤泡辅助细胞淋巴瘤血管免疫母细胞性眼损害
Seiya Bamba,Masashi Nishikubo,Shin-Ichiro Ito et al.
Seiya Bamba et al.
Post-Varicella Purpura Fulminans With Extensive Skin Necrosis in a Child [0.03%]
一例儿童继发水痘的广泛性皮肤坏死综合征病例报告
Madalena Correia Pires,Ana Costa E Castro,Filipa Marujo et al.
Madalena Correia Pires et al.
Clonal Evolution and Lineage Switch from T-Cell Acute Lymphoblastic Leukemia to Acute Myeloid Leukemia in Therapy-Resistant PICALM::MLLT10 Leukemia [0.03%]
治疗抵抗性PICALM::MLLT10白血病向急性髓系白血病的克隆进化和谱系转换来源T细胞急性淋巴细胞白血病
Machiko Kawamura,Daichi Sadato,Masayuki Haruta et al.
Machiko Kawamura et al.
Background: PICALM::MLLT10-positive T-ALL is rare and associated with poor prognosis. Lineage switch to AML is exceptionally uncommon, particularly after long-term remission. ...